Endocrine Research Updates
For Medical Professionals
EndocrineWeb features highlights of recent government activities, new product announcements, and brief study findings to keep you informed of advances in diabetes care management.
With hip fractures rates on the rise, a concerted effort is needed to revisit regular bone screenings, and bisphosphonate treatment including education about the reality of side effects.
Quick overview of new medical device regulations, devices, and software to inform your practice and may be of interest to trial with your patients.
Implications for intransigent obesity may be related first to your patients’ metabolic inflexibility and only secondarily to their diet, and may offer an early warning sign of diabetes. .
Peer-reviewed recommendations to change the diagnosis criteria and treatment considerations for thyroid storm reflect observed patient experiences that go beyond current common sense practices.
Addressing behaviors such as diet, physical activity, weight, and smoking appear to mediate development of cardiovascular disease in women who had gestational diabetes.
Slightly low thyroid stimulating hormone levels may offer a reason why some women struggle to get pregnant suggest Harvard researchers.
PCOS puts women at increased risk for steatosis and fibrosis with insulin resistance and hyperandrogenism as key factors in liver damage of these patients.
Boosting gut microflora may yield improvements linked to reduced dysbiosis, and potential for long-term benefit against chronic diseases.
Taking a patient-centered approach to glycemic goals rather than intensive HbA1C targets promises substantially reduced costs and improve quality of life over the lifetime.
While promising, there is no way to know whether introducing lifestyle changes to patients who are diagnosed earlier will positively effect their outcomes.
Recent research uncovers a wide variation in reference ranges for pediatric thyroid function and points to possible factors affecting thyroid hormone levels in children.
Researchers followed patients who were newly diagnosed with type 2 diabetes for 18 months to classify their disease progression based on 20 baseline symptoms.
Direct intervention with an assigned appointment specialist dramatically improved retention rates and better disease outcomes among pediatric patients with type 1 Diabetes as they were transitioned to adult care.
Changes to the eighth edition of the American Joint Commission on Cancer/Union for International Cancer Control 's criteria for tumor staging offer better prognosis for many patients diagnosed with papillary thyroid cancer.
Two internationally recognized women's health experts raise concerns from use of hormone therapy from a compounding pharmacy to manage menopausal symptoms.
Bipartisan legislation formalizing the integration of programs and activities focused on diabetes across federal agencies heads to the President for his signature.
A new ultra-rapid injectable synthetic insulin has been added to Novo Nordisk's antidiabetes product line-up.
Analyses of insulinomas provide pathway to pharmacologically target genes and gene families that may restore function of beta cells in individuals with type 1 and type 2 diabetes.
A secondary analysis of the Fourier study findings indicates that patients with the lowest LDL had best cardiovascular outcomes.
